diallyl trisulfide has been researched along with deferoxamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antosiewicz, J; Herman-Antosiewicz, A; Marynowski, SW; Singh, SV | 1 |
| Antosiewicz, J; Borkowska, A; Fedeli, D; Herman-Antosiewicz, A; Jozwik, A; Sielicka-Dudzin, A; Wozniak, M | 1 |
2 other study(ies) available for diallyl trisulfide and deferoxamine
| Article | Year |
|---|---|
c-Jun NH(2)-terminal kinase signaling axis regulates diallyl trisulfide-induced generation of reactive oxygen species and cell cycle arrest in human prostate cancer cells.
Topics: Allyl Compounds; Cell Cycle; Cell Division; Cell Line, Tumor; Deferoxamine; Ferritins; G2 Phase; Humans; Iron; Iron Chelating Agents; JNK Mitogen-Activated Protein Kinases; Male; Prostatic Neoplasms; Reactive Oxygen Species; Signal Transduction; Sulfides | 2006 |
Impact of JNK1, JNK2, and ligase Itch on reactive oxygen species formation and survival of prostate cancer cells treated with diallyl trisulfide.
Topics: Allyl Compounds; Cell Line, Tumor; Cell Survival; Comet Assay; Deferoxamine; DNA Damage; Ferritins; Humans; Iron; Male; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinase 9; Oxidative Stress; Phosphorylation; Prostatic Neoplasms; Reactive Oxygen Species; Repressor Proteins; Signal Transduction; Sulfides; Ubiquitin-Protein Ligases | 2012 |